250+ investors that invest in your industry and stage Get
Any industry
Energy
Proptech
Community
Health Care
Gaming
Artificial Intelligence
Climate
Biotech
Impact
Google
EdTech
Sustainability
Venture Capital
Clean Energy
Finance
Retail
Digital Media
Local
Enterprise Software
Email
Travel
Recruiting
Platforms
Fitness
Wine and Spirits
Crowdfunding
Social
CleanTech
Mobile Apps
InsurTech
LGBT
Infrastructure
Oil and Gas
Fashion
Theatre
Sporting Goods
Non Profit
Renewable Energy
Social Impact
Restaurants
Celebrity
Cryptocurrency
SaaS
Machine Learning
Agriculture (AgTech)
Media (Entertainment)
Blockchain
Facebook
Publishing
Beauty
Real Estate
Life Science
B2B
Film
Web3
Big Data
Organic Food
Video Games
Medical Device
Medical
Wellness
Education
Payments
Art
Social Media
Photography
Music
Franchise
Android
Mobile
Internet
Legal
Construction
eSports
Manufacturing
Sports
Automotive
Hospitality
Financial Services
Mobile Advertising
Cannabis
Biotechnology
FinTech
Consumer
Marketplace
Hardware
Transportation
Food and Beverage
Social Network
Enterprise
Software
Any country
Australia
South Korea
Europe
Brazil
Indonesia
Singapore
Saudi Arabia
Africa
Oceania
LATAM
Asia
Middle East
Costa Rica
Gibraltar
Bahrain
Greece
Finland
Liberia
Mexico
Lebanon
Norway
Mauritius
Italy
Israel
Taiwan
Tunisia
Zambia
Russian Federation
Tajikistan
Sweden
Zimbabwe
Togo
Puerto Rico
San Marino
Nigeria
Jamaica
Honduras
Isle of Man
Mozambique
Luxembourg
Albania
Pakistan
Romania
Bangladesh
Algeria
Kazakhstan
Kenya
Cayman Islands
Cambodia
Oman
Guatemala
Cameroon
Colombia
China
Seychelles
Ireland
New Zealand
Cyprus
India
Germany
Canada
United Kingdom
Qatar
South Africa
Spain
Sri Lanka
Armenia
Azerbaijan
Austria
Barbados
Argentina
Vietnam
United Arab Emirates
Bulgaria
Belarus
Estonia
Belgium
Bermuda
Bolivia
Egypt
France
Bahamas
Czech Republic
Chile
Denmark
Faroe Islands
Georgia
Ecuador
Belize
Croatia
Dominican Republic
Hong Kong
Switzerland
Ethiopia
Grenada
Ghana
Iraq
Hungary
Iceland
Jersey
Jordan
Kuwait
Liechtenstein
Lithuania
Morocco
Latvia
Mali
Marshall Islands
Myanmar
Malta
Malaysia
Nicaragua
Namibia
Peru
Philippines
Poland
Panama
Portugal
Rwanda
Sierra Leone
Serbia
Slovenia
Senegal
El Salvador
Thailand
Tanzania
Uruguay
Turkey
Ukraine
Uganda
Uzbekistan
Venezuela
United States
Japan
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Find investors

Top 50 Biotechnology VC Funds & Investors in Finland (June 2026)

The most active venture capital funds investing in Finland Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Finland Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Business Finland
VC Fund
10 Finland, United States, United Kingdom Seed, Grant, Debt Financing Software, SaaS, Biotechnology $48k–$11M
Tesi
VC Fund
9 Finland, United States, Switzerland Series A, Series B Software, Manufacturing, Health Care $2.2M–$41M
Voima Ventures
VC Fund
9 Finland, Sweden, Norway Seed, Pre-Seed, Series A Biotechnology, Health Care, Artificial Intelligence $439k–$18M
Lifeline Ventures
VC Fund
9 Finland, United States, United Kingdom Seed, Series A Software, Health Care, E-Commerce $547k–$20M
Finnvera Venture Capital
VC Fund
8 Finland, United States, Switzerland Seed, Series A Software, Health Care, Information Technology $250k–$22M
Springvest
VC Fund
5 Finland Series A, Seed Biotechnology, Health Care, Energy $3.6M–$53M
Butterfly Ventures
VC Fund
5 Finland, Sweden, Norway Seed, Pre-Seed Health Care, Software, Information Technology $110k–$4.4M
Icebreaker.vc
VC Fund
4 Finland, Estonia, Sweden Pre-Seed, Seed, Series A Software, Information Technology, Artificial Intelligence $106k–$25M
Nordic Foodtech VC
VC Fund
3 Finland, Sweden, Denmark Seed, Series A Biotechnology, Life Science, Water $549k–$18M
Innovestor
VC Fund
3 Finland, Denmark, Sweden Seed, Pre-Seed Software, Health Care, Information Technology $163k–$4.1M
Stephen Industries
VC Fund
3 Finland, Sweden Seed, Pre-Seed, Series A Health Care, Biotechnology, Apps $330k–$45M
Nordic Science Investments
VC Fund
2 Finland, Sweden Seed, Pre-Seed, Series A Biotechnology, Medical, Health Diagnostics $380k–$4.6M
Finnish Climate Fund
VC Fund
2 Finland Debt Financing, Series A Energy, Renewable Energy, Manufacturing $2.6M–$14M
Fazer
VC Fund
2 Finland Series A, Series B Biotechnology, Food Processing
VTT Ventures
VC Fund
2 Finland Seed, Series A Biotechnology, Manufacturing, Sensor $460k–$13M
Sofinnova Partners
VC Fund
2 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $6M–$102M
European Investment Bank
VC Fund
2 Germany, France, The Netherlands Debt Financing, Post-IPO Debt Biotechnology, Health Care, Energy
EQT Life Sciences
VC Fund
2 United States, The Netherlands, Switzerland Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.9M–$140M
Pontos Group
VC Fund
2 Finland Genetics, Hospital, Automotive
HealthCap
VC Fund
2 United States, Sweden, France Series B, Series A Biotechnology, Health Care, Medical $5.7M–$88M
Inventure
VC Fund
2 Finland, Sweden, United States Seed, Series A, Series B Software, Information Technology, Health Care $549k–$23M
Sitra
VC Fund
2 Finland, The Netherlands Series A, Series C Health Care, Biotechnology, Therapeutics
Midinvest Management
VC Fund
1 Finland Seed, Convertible Note Software, Information Technology, Internet $193k–$260k
Emerald Technology Ventures
VC Fund
1 United States, Germany, Finland Series B, Series A Manufacturing, Software, Energy $4M–$129M
Takoa Invest
VC Fund
1 Finland, Israel Seed, Series B, Series C Biotechnology, Mobile, Retail $483k–$1.3M
Loudspring
VC Fund
1 Finland, Sweden, United States Series A, Seed Software, SaaS, Retail
Unifund
VC Fund
1 Finland Software, Collaboration, Management Consulting
Ananda Impact Ventures
VC Fund
1 Germany, United Kingdom, Finland Seed, Series A Health Care, Software, Information Technology
The Forum Corporation
VC Fund
1 Finland Series A Biotechnology
Moomin Characters
VC Fund
1 Finland Seed Biotechnology, Environmental Engineering
XR Invest
VC Fund
1 Finland, United States Series A, Series C Medical Device, Sensor, Medical
Visionplus
VC Fund
1 Finland, United States, United Kingdom Seed, Series A Software, Information Technology, Internet
Oy Hammaren & Co Ab
VC Fund
1 Finland Angel, Series A Health Care, Wellness, GreenTech
Lynx Capital
VC Fund
1 Finland Series A Therapeutics, Biotechnology, Pharmaceutical
Gaingels
VC Fund
1 United States, Canada, United Kingdom Seed, Series A, Series B Software, Health Care, Artificial Intelligence
Novartis Venture Fund
VC Fund
1 United States, Switzerland, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $4.7M–$105M
Aqua Spark
VC Fund
1 United States, Norway, Israel Series A, Seed Biotechnology, Aquaculture, Seafood
Lundbeckfonden Ventures
VC Fund
1 United States, Denmark, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $10M–$95M
Agronomics
VC Fund
1 United States, Finland, Germany Series A, Seed, Series B Biotechnology, Food and Beverage, Food Processing $894k–$55M
K5 Global
VC Fund
1 United States, United Kingdom, Brazil Seed, Series A, Pre-Seed Software, Information Technology, Artificial Intelligence $50k–$50M
Conor Venture Partners
VC Fund
1 Finland, United States, Sweden Series A, Series B, Seed Software, Analytics, Semiconductor $1.1M–$16M
Capricorn Partners
VC Fund
1 Belgium, United States, The Netherlands Series A, Series B Biotechnology, Health Care, Software $3.3M–$42M
H&M Group Ventures
VC Fund
1 Sweden, United States, United Kingdom Series A, Series B E-Commerce, Fashion, Textiles $1.9M–$50M
Keksintösäätiö
VC Fund
1 Finland Seed Apps, Health Care, Biotechnology
Thames Trust
VC Fund
1 United Kingdom, Finland Seed, Series A, Series B SaaS, FinTech, Finance
Metsola Ventures
VC Fund
1 Finland Series A Medical, mHealth, Health Care $2.2M–$4.8M
CPT Capital
VC Fund
1 United States, Israel, United Kingdom Series A, Seed, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
Broadview Ventures
VC Fund
1 United States, Canada, Israel Series A, Seed, Series B Health Care, Biotechnology, Medical Device $1M–$45M
Athensmed
VC Fund
1 Finland Seed, Series A Health Care, Medical, mHealth $1.1M–$1.3M
Zhejiang Huahai Pharmaceutical
VC Fund
1 China, Finland Series A Biotechnology, Pharmaceutical, Therapeutics
Access all 108 VC funds in Finland Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Business Finland
VC Fund · Helsinki, Southern Finland, Finland · 10 investments in Finland Biotechnology startups

Business Finland finances business R&D projects and public research projects at universities, research institutes and universities of applied sciences. Read more about R&D and business funding.

Show more...

Investment focus

  • Industry: Software, SaaS, Biotechnology
  • Stage:Seed, Grant, Debt Financing
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 181
  • Round size: Seed $127k–$4.2M; Grant $48k–$11M; Debt Financing $212k–$4.9M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • SSAB
  • Valio — We are Valio Group: the most innovative dairy and food company in the world.
  • Jaakko.com — Reinventing the housing market with no agents, more homes, and less fees.
Show all investments...

Tesi
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Biotechnology startups

Finnish Industry Investment Ltd is a government-owned investment company. It invests the proceeds accrued from the privatisation of state-owned companies in stimulating the growth and internationalisation of Finnish businesses.Finnish Industry Investment invests in venture capital funds and directly in growth companies, together with privateco-investors. The targets are in all sectors. Capital investments are needed for financing the growth of investee companies, and for spin-offs, major industrial investments, and sector and corporate restructurings.The investments of Finnish Industry Investment amount to over MEUR 570

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Series A, Series B
  • Geography: Finland, United States, Switzerland

Investor stats

  • Total investments: 142
  • Round size: Series A $2.2M–$41M; Series B $3.1M–$35M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
  • Wirepas — Wirepas offers a standards-based, ultra-reliable mesh connectivity for infrastructure-grade IoT. Proven in millions of devices worldwide.
  • MaaS Global — Whim combines all the transportation you need: Public transport, shared cars, bikes, e-scooters, taxis, and more! One app to plan, book, and pay.
Show all investments...

Voima Ventures
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Biotechnology startups

Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 59
  • Round size: Seed $1M–$5.5M; Pre-Seed $439k–$2.1M; Series A $3.8M–$18M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • MVision AI — AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.
  • Quantrol Ox — Building Machine Learning Based Software for Quantum Control with a goal to maximise quantum computer uptime.
  • Adamant Health — Adamant Health’s unique technology to analyse Parkinson’s disease symptoms is based on over 15 years of academic research at the University of Eastern Finland. With the technology, clinicians have several days detailed visibility to the patient’s symptoms and is able to optimise the treatment accordingly. Pharma companies benefit from the objectiveand long-term RW data in their clinical and post market studies and can utilise it as complementary diagnostics tool for personalised medication.
Show all investments...

Lifeline Ventures
VC Fund · Helsinki, Southern Finland, Finland · 9 investments in Finland Biotechnology startups

Lifeline Ventures Oy is a venture capital firm specializing in startups, growth capital, and early stage investments. The firm seeks to invest in healthcare, games, web based and general high technology sectors. It seeks to invest in Finland with a few investments made outside Finland as well. The firm targets investing between €0.5 million ($0.66million) and €1 million ($1.32 million). It seeks make inception to Series A investments. Lifeline Ventures Oy was founded in November 2009 and is based in Helsinki, Finland.

Show more...

Investment focus

  • Industry: Software, Health Care, E-Commerce
  • Stage:Seed, Series A
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 178
  • Round size: Seed $547k–$5.4M; Series A $2.7M–$20M
  • Lead/follow: 38% lead, 62% follow
  • Last fund: Likely still investing — raised $171M in 2023

Portfolio highlights

  • ICEYE — Gain access to timely and reliable SAR imaging from the world's leading New Space SAR satellite constellation.
  • Carbo Culture — We are a project developer with proprietary climate technology. We are building a rapidly scalable biochar carbon removal solution.
  • Everywear Games — Metacore is a wearable game studio. The company was founded in 2014 by industry veterans from Remedy, Digital Chocolate and Rovio and it is the pioneer of smartwatch gaming. It’s award-winning Apple Watch launch title, Runeblade, has received worldwide recognition from press, fans and industry heavyweights and it’s games are consistently on top ofglobal charts.
Show all investments...

Finnvera Venture Capital
VC Fund · Kuopio, Eastern Finland, Finland · 8 investments in Finland Biotechnology startups

Finnvera makes direct investments in early-stage enterprises through Seed Fund Vera Ltd. Finnvera's goal is to cover shortcomings existing on the market between product development funding and private equity investments. Finnvera does not compete with private financiers; instead, it strives to supplement the financial market.Finnvera'sinvestments enable, start and accelerate growth and internationalisation among investment targets. Enterprises are developed to make them attractive targets for further financing by other investors and industrial actors. Investments are made in technology enterprises at an early stage and in technology-intensive or innovative service enterprises that have potential for developing into international growth enterprises.Finnvera is also known as a specialised financing company owned by the State of Finland. It provides its clients with loans, guarantees, venture capital investments and export credit guarantees.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Finland, United States, Switzerland

Investor stats

  • Total investments: 92
  • Round size: Seed $250k–$1.5M; Series A $1.7M–$22M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • ARAUCO — ARAUCO is a diversified global company in the forestry industry. They use world-class technologies and processes throughout the value chain. They are present in the forestry, pulp, timber, panels and renewable energy businesses.
  • Nexstim — Nexstim is a medical device company that specializes in image-guided transcranial magnetic stimulation. The company is committed to improving the quality of life of patients with significant unmet clinical needs. It has developed a SmartFocus TMS technology designed for the treatment of the major depressive disorder.The company was founded in2000 and is headquartered in Helsinki, Southern Finland.
Show all investments...

Springvest
VC Fund · Helsinki, Southern Finland, Finland · 5 investments in Finland Biotechnology startups

The Citizenship Fund started out when the founders of the company discovered in their previous positions that a promising Finnish growth company will spend a great deal of time and energy in arranging financing. A good business idea and a team with excellent team could take months in financial negotiations and the outcome could be a return to thestart-up. At the same time, investors often wanted new types of higher potential investments alongside traditional alternatives.These two challenges were possible by removing the promising growth companies as investors, even for non-traditional venture capital investors. Citizenship wanted to create a service in which the company would be able to capitalize on business quickly and flexibly, but the decision-making business would be left to the company itself. From today's point of view, Springvest's goal is that an increasing number of Finnish investors can get involved in the story of Finnish growth companies and potential success.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Series A, Seed
  • Geography: Finland

Investor stats

  • Total investments: 20
  • Round size: Series A $3.6M–$53M
  • Lead/follow: 80% lead, 20% follow

Portfolio highlights

  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Show all investments...

Butterfly Ventures
VC Fund · Oulu, Oulu, Finland · 5 investments in Finland Biotechnology startups

Butterfly Ventures is a seed-stage focused VC in the Nordics, investing in deep tech, hardware, and hardware interfacing software. The company prefers to get involved with companies early on; 80% of Butterfly Ventures portfolio companies don't have any revenue at the time of their entry. Butterfly Ventures was founded in 2012 and ever sincethen it has been one of the most active early stage VCs in the region. The company has offices in Oulu, Helsinki and Stockholm.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Sweden, Norway

Investor stats

  • Total investments: 86
  • Round size: Seed $219k–$2.1M; Pre-Seed $110k–$4.4M
  • Lead/follow: 42% lead, 58% follow

Portfolio highlights

  • 10Lines — Explore cutting-edge pavement marking robots for faster, autonomous striping and significant CO2 reduction. Contact us now!
  • CooliBlade — Superior power electronics cooling solutions for applications like solar and wind energy, energy storage, EV charging and telecommunications.
  • Popit — Popit makes medication connected with a unique, medical grade solution. It tracks medication use automatically and reminds ONLY if you miss. Developed together with healthcare professionals.
Show all investments...

Icebreaker.vc
VC Fund · Helsinki, Southern Finland, Finland · 4 investments in Finland Biotechnology startups

Founded in 2016, Icebreaker has invested in over 50 fast-growing tech startups built by domain expert founders from companies like Rovio, Nordea, Pipedrive, Eniram, IBM and BCG. In addition to the fund, Icebreaker also runs a community of more than 1000 founders and pre-founders with 5+ years of relevant industry experience and the will to start,build or join strong tech companies.With the initial ticket sizes of €150k - 800K Icebreaker provides enough funding for companies to get to a position of strength and avoid post-accelerator limbo without having to resort to disreputable sources of capital and unfriendly deal terms.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Finland, Estonia, Sweden

Investor stats

  • Total investments: 121
  • Round size: Seed $384k–$5.2M; Pre-Seed $106k–$1.3M; Series A $3.1M–$25M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — raised $22M in 2021

Portfolio highlights

  • Cytely — Transforms microscopy from image-driven to data-driven through AI-powered autonomous targeting that captures high-resolution data of critical cellular events, enabling researchers to solve complex biological problems in minutes instead of years.
  • ReOrbit — Looking for a way to keep your data flowing in space? ReOrbit has you covered with our line of autonomous and inter-networking satellites!
  • NROC Security — Prevent data leaks, govern shadow AI, prove compliance, and save 50% on GenAI subscriptions
Show all investments...

Nordic Foodtech VC
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Biotechnology startups

We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food

Show more...

Investment focus

  • Industry: Biotechnology, Life Science, Water
  • Stage:Seed, Series A
  • Geography: Finland, Sweden, Denmark

Investor stats

  • Total investments: 26
  • Round size: Seed $549k–$5.5M; Series A $7.4M–$18M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $49M in 2021

Portfolio highlights

  • EvodiaBio — Mirroring nature with pioneering bioscience for natural flavors
  • Endless Food — Endless Food Co is a food innovation firm focusing on the junction of pleasure and sustainability. Endless Food Co was pulled together by a common idea that the transition to a greener and more egalitarian future food system will be driven by flavor, and having spent the last decade pioneering sustainable gastronomy
  • Happy Plant Protein — Revolutionize plant protein production with Happy Plant Protein's innovative technology, transforming local ingredients into high-quality, sustainable solutions for the food industry.
Show all investments...

Innovestor
VC Fund · Helsinki, Southern Finland, Finland · 3 investments in Finland Biotechnology startups

Innovestor is an active Finnish investment manager, focusing on venture capital, real estate, and energy storage. We also offer corporate venturing services.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Pre-Seed
  • Geography: Finland, Denmark, Sweden

Investor stats

  • Total investments: 74
  • Round size: Seed $507k–$4.1M; Pre-Seed $163k–$2M
  • Lead/follow: 62% lead, 38% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • Bahn Express — Bahn Express is a global car transportation company that supports independent contractors while offering quick and easy auto shipping throughout Europe.
  • Teitur Trophics — Teitur Trophics is a biotech company developing circular peptides for neurodegenerative diseases. The company was founded in 2020 and is headquartered in Aarhus, Denmark.
  • Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Stephen Industries
VC Fund · Espoo, Southern Finland, Finland · 3 investments in Finland Biotechnology startups

We fund futurebreakthroughs

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Apps
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden

Investor stats

  • Total investments: 13
  • Round size: Seed $1.4M–$8.3M; Pre-Seed $330k–$4.4M; Series A $8.4M–$45M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • StemSight — StemSight is a Finnish high-tech startup developing cell therapies for corneal blindness using human pluripotent stem cells.
  • HYPERMINE — Hypermine a novel laser-based mineralogy sensing technology to optimize resource recovery and reduce the negative environmental effects of mining.
  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Show all investments...

Nordic Science Investments
VC Fund · 2 investments in Finland Biotechnology startups

We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Diagnostics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Finland, Sweden

Investor stats

  • Total investments: 10
  • Round size: Seed $1.1M–$4.6M; Pre-Seed $380k–$837k
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • AIATELLA — Automating medical image analysis
  • CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
  • SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Show all investments...

Finnish Climate Fund
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

The Climate Fund focuses on combating climate change, boosting low-carbon industry and promoting digitalisation.

Show more...

Investment focus

  • Industry: Energy, Renewable Energy, Manufacturing
  • Stage:Debt Financing, Series A
  • Geography: Finland

Investor stats

  • Total investments: 20
  • Round size: Debt Financing $2.6M–$14M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • AISTI — AISTI develops wood fiber-based acoustic tiles that are carbon negative, easy to recycle and plastic-free – bringing sustainability to construction tile by tile.
  • Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
  • Volare — Refining food industry side streams into sustainable protein, oil and fertilizers.
Show all investments...

Fazer
VC Fund · Vantaa, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Fazer Group mission is to create taste sensations. Customer orientation, quality and operations are based.

Show more...

Investment focus

  • Industry: Biotechnology, Food Processing
  • Stage:Series A, Series B
  • Geography: Finland

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
Show all investments...

VTT Ventures
VC Fund · Espoo, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

VTT is a powerhouse of technology development and scientific research. Many of the most significant Finnish technology start-ups were brought to life at VTT. Do you want to invest in ongoing ventures?

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Sensor
  • Stage:Seed, Series A
  • Geography: Finland

Investor stats

  • Total investments: 24
  • Round size: Seed $460k–$6M; Series A $1.7M–$13M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Dispelix — See-through, full color waveguide combiners for a wide range of XR applications. From near-eye to head-up.
  • Solar Foods — The Finnish company Solar Foods Oy produces an entirely new kind of nutrient-rich protein using only air and electricity as the main resources. The goal of the company is to start commercial production of the environmentally revolutionary protein in 2020.Solar Foods’ concept redefines the basics of food production, as it is not dependent onagriculture, the weather, or the climate. The price of the protein product is also competitive compared to sources such as soy protein.
  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 2 investments in Finland Biotechnology startups

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 298
  • Round size: Series A $6M–$65M; Series B $10M–$102M; Series C $11M–$100M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $200M in 2023

Portfolio highlights

  • protera — Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities in food, agriculture, the environment and human health. We streamline protein design and development with MADI, our proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed.Our in-house lab generates small quantities of the new predicted structures to validate their desired performance. Upon lab validation, we collaborate with our clients on next steps to move from pilot to industrial scale production.
  • Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
  • T-Therapeutics — T-Therapeutics is a expertise in mouse genome engineering, deep expertise in biopharmaceutical drug development, single cell genomics, machine-learning and structural biology, anchored in a culture of creativity and collaboration. .
Show all investments...

European Investment Bank
VC Fund · Luxembourg, Luxembourg, Luxembourg · 2 investments in Finland Biotechnology startups, 25 in the past 12 months

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Energy
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: Germany, France, The Netherlands

Investor stats

  • Total investments: 247
  • Lead/follow: no public data

Portfolio highlights

  • Amadix — Amadix develops and commercializes breakthrough discoveries in cancer diagnosis with a clear commercial rationale, addressing unmet medical needs in oncology. After analytical validation and demonstration of clinical validity and utility through international multicentre studies, the products will be commercialized worldwide.The most advancedproduct developed by Amadix is Colofast, an innovative non-invasive screening signature for colorectal cancer (CRC) and advanced adenoma diagnosis in blood designed to solve a significant health priority: the high mortality rate due to colon cancer worldwide (around half of the diagnosed patients).Amadix team consist of industry veterans with robust expertise in the Oncology Diagnostic area. They are a top level management team with international experience in cancer diagnostics, the pharmaceutical industry, the biotechnology sector and intellectual property. Amadix also has independent board members with international profiles and many years of experience in oncology and diagnostics, who advise the management team on strategy, commercialization and business development in Europe and the US.
  • Greenlight Biosciences — Next Generation Crop Protection
  • Azienda Comprensoriale Acquedottistica — ACA Spa is an integrated water service company.
Show all investments...

EQT Life Sciences
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Finland Biotechnology startups

Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, The Netherlands, Switzerland

Investor stats

  • Total investments: 168
  • Round size: Series A $6.9M–$77M; Series B $8.6M–$103M; Series C $12M–$140M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $266M in 2023

Portfolio highlights

  • Neuravi — Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies.
  • Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
  • Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
Show all investments...

Pontos Group
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Pontos is a family owned Finnish private equity and real estate investment company operating in Finland, the Baltic States, and Portugal.

Show more...

Investment focus

  • Industry: Genetics, Hospital, Automotive
  • Geography: Finland

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • R8tech — R8 Jenny is AI HVAC technology for commercial real estate. It helps you achieve ESG goals while saving up to 30% in energy costs!
  • Valmet Automotive — Valmet Automotive, a Uusikaupunki, Finland-based electric vehicle developer and manufacturer. Valmet Automotive provides engineering, manufacturing and business services for the automotive industry. In 2009, the company generated net sales of €56m and employed some 800 people. It manufactures Porsche Cayman sports cars, electric Garia golf carsand THINK City urban cars in Uusikaupunki, Finland. Cuca
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Show all investments...

HealthCap
VC Fund · Stockholm, Stockholms Lan, Sweden · 2 investments in Finland Biotechnology startups

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A
  • Geography: United States, Sweden, France

Investor stats

  • Total investments: 121
  • Round size: Series A $5.7M–$55M; Series B $14M–$88M
  • Lead/follow: 24% lead, 76% follow
  • Last fund: May invest from a new fund soon — raised $209M in 2019

Portfolio highlights

  • ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
  • HelloBetter — HelloBetter (hellobetter.de) was founded in 2015 under the name GET.ON Institut für Online Gesundheitstrainings GmbH (geton-institut.de) by internationally renowned research psychologists, and in close partnership with one of the largest public health care insurance companies in Germany (BARMER). HelloBetter is a pioneer in the field of e-mentalhealth and a leading provider of online mental health courses. Its work has a strong scientific basis – the courses were developed, evaluated, and implemented in a practice setting, and their effectiveness has been proven in 33 randomized controlled trials according to the highest standards of scientific practice. HelloBetter offers the widest range of evidence-based online mental health courses worldwide, with 11 digital courses covering 8 problem areas (stress, depression, insomnia, depression in the case of chronic illness, chronic pain, alcohol consumption, excessive worry, and panic and anxiety).In October 2021, the digital therapeutic 'HelloBetter Stress and Burnout' has been permanently approved by the German Federal Institute for Drugs and Medical Devices (BfArM) as a Digital Health Application (DiGA) and thus is available by prescription free of charge for more than 50 million adults. It is the world’s first and so far only prescription digital therapeutic for the treatment of burnout symptoms.Through diverse cooperations with national and international research groups (including FAU Erlangen, University of Ulm, VU Amsterdam, and Harvard University) HelloBetter finds practical applications for the latest research innovations. Our products and our team have been awarded numerous national and international prizes. These include the Novartis & Sandoz/Hexal Digital Health Prize 2018, the Comenius Award of the European Federation of Psychologists’ Association, and the Good Practice in Mental Health & Wellbeing seal of approval as part of the EU Compass 2018, which recognises high-quality mental health initiatives in Europe in order to guide health care providers to effective and proven services.
  • Tribune Therapeutics — Tribune Therapeutics is a preclinical biopharmaceutical company building a promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases. It was founded in 2020 with funding from HealthCap and Novo Seeds.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Inventure
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 164
  • Round size: Seed $549k–$6M; Series A $1.3M–$17M; Series B $1.3M–$23M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: Likely still investing — raised $169M in 2022

Portfolio highlights

  • Omocom — Omocom offers safe, simple and secure insurance for all kind of renting, sharing and re-using, digitally, automated and integrated into the sales flow of the platform
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
  • Blueprint Genetics — We offer complete genetic testing and genetic diagnostics to medical professionals worldwide. Learn more about our winning clinical-grade NGS offering!
Show all investments...

Sitra
VC Fund · Helsinki, Southern Finland, Finland · 2 investments in Finland Biotechnology startups

Sitra is the venture capital investment arm of Sitra specializing in investments in seed, start-ups, early stage opportunities, and other funds. The firm invests through its three programmes namely, Health Care Programme, the Food and Nutrition Programme, and the Environmental Programme. Within the Health Care Programme, investments are focused oncompanies engaged in paper-free health care, seamless services, decentralised specialised health care, and support services. Within the Food and Nutrition Programme, investments are made in enterprises engaged in the food and nutrition sector, including value-adding upgrading of raw materials and new applications and service concepts in food and nutrition technology.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Series A, Series C
  • Geography: Finland, The Netherlands

Investor stats

  • Total investments: 7
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • SET Ventures — SET propels founders from early growth to European scale. We invest in and grow the solutions powering the digital energy economy.
Show all investments...

Midinvest Management
VC Fund · Jyväskylä, Western Finland, Finland · 1 investments in Finland Biotechnology startups

Midinvest Management is a Finnish private equity firm specialized in ownership arrangements for small- and medium-sized enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Convertible Note
  • Geography: Finland

Investor stats

  • Total investments: 4
  • Round size: Seed $193k–$260k
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • Quosis — As of March 18, 2008, Quosis Oy was acquired by Proactum Oy. Quosis Oy operates as an open source software service company. It offers open-source based solutions and services, including portal solution for managing organization’s information and services; content management for gathering, sharing, saving, and producing information; businessprocess management for automating, monitoring, managing, and improving key processes; integration of information systems; and instant messaging for improving the organizational information exchange. The company also offers open source consultation and software development services. It serves the paper industry. The company was founded in 2004 and is headquartered in Jyvaskyla, Finland.
  • Howspace — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
Show all investments...

Emerald Technology Ventures
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Finland Biotechnology startups

Emerald Technology Ventures specializes in clean technology venture capital. Emerald focuses on the areas of energy, water, and materials. , Emerald manages several venture capital funds and venture capital portfolio mandates.

Show more...

Investment focus

  • Industry: Manufacturing, Software, Energy
  • Stage:Series B, Series A
  • Geography: United States, Germany, Finland

Investor stats

  • Total investments: 91
  • Round size: Series A $4M–$14M; Series B $5.5M–$129M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $212M in 2022

Portfolio highlights

  • Vytal — Start the Packaging Revolution! We are offering smart & reusable To-Go Packaging-as-a-Service to gastronomy clients & consumers.In Germany the consumption of take-away, convenience and delivery food & drinks is responsible for about 281 kilotons of single-use packaging waste for immediate consumption and is growing at double digitrates. Most of the time, To-Go food containers, snack boxes or coffee cups have a very short life-span of only 30 minutes after which they are tossed into trash (or litter parks, beaches & the ocean). This is not only a giant waste of economic resources as each single use costs between 15 and up to 0,60€ for a stable bowl/box with a lid. It is a horrendous waste of environmental resources (wood, water, crude oil, metals & energy) that are used to produce this packaging. Therefore, a single use packaging not weighing more than 30 grams can easily come with an ecological backpack of more than 8 kilograms when taking into account all the resources used in production (material intensities taken from Wuppertal Institute for Climate, Environment and Energy). Looking at GHG emissions, the picture is similarly bleak: Using CO2 emission factors and the detailed material mix of the single-use packaging waste analyzed by NABU (German Nature and Biodiversity Conservation Union), the 281 thousand tons waste from To-Go consumption generated around 556 thousand tons of CO2 or the equivalent of 195k passenger cars per year (assuming an average distance travelled of 15,000km). With the expected rise of take-away, convenience and delivery food, the related emissions are expected to increase at double digit rates as waste volume is expected to increase and as we saw a shift to plastics relative to cardboard or other materials. While there is a growing awareness of the problem, especially in Germany, there is no scalable solution yet and the commonly used alternative of nature-based & ‘biodegradable’ materials like bagasse or PLA also require many resources for production & transport, and have to be incinerated or go to landfill after use as there is currently no way to compost them.
  • Cajo Technologies — Laser Marking - Cajo turnkey solutions for traceability & product markings. Easy to use & optimized for industrial production processes.
  • NLM Photonics — Data centers consume enormous amounts of power; our faster, energy-efficient electro-optic modulation solution moves data across the internet.
Show all investments...

Takoa Invest
VC Fund · 1 investments in Finland Biotechnology startups

Takoa Invest is a Finnish family-owned investment company that owns and develops companies and properties with growth potential in Finland and abroad. Takoa Invest is a Finnish family-owned investment company. It owns and develops companies and properties with growth potential in Finland and abroad.

Show more...

Investment focus

  • Industry: Biotechnology, Mobile, Retail
  • Stage:Seed, Series B, Series C
  • Geography: Finland, Israel

Investor stats

  • Total investments: 4
  • Round size: Seed $483k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Theranica — Theranica is a medical device company that has combined neuromodulation therapy with modern wireless technology to develop proprietary wearable solutions that address various medical conditions and disease states. The noninvasive and therapeutic 'smart' patches are controlled by a smartphone app to allow for personalized, portable, andaffordable care. The patch consists of a proprietary 'smart' chip that delivers electrical pulses to neuro-modulate the sensory nerves under the skin. The first application of the technology is for treatment of migraine headaches.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • IndoorAtlas — Discover the power of indoor positioning technology with IndoorAtlas. Build innovative indoor location-based solutions using our cross-platform SDK. Explore case studies and start developing today.
Show all investments...

Loudspring
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Loudspring is a cleantech accelerator in the Nordic region, boasting several fast growing and high impact companies that solve global challenges. The portfolio companies are active in energy- and resource efficiency as well as decentralized renewable energy and are based in Finland, Sweden and Germany. The company management consists of companybuilders and investors who have been active within the cleantech space for over a decade.The company is listed on First North Finland under the ticker LOUD and on First North Stockholm under the ticker LOUDS.

Show more...

Investment focus

  • Industry: Software, SaaS, Retail
  • Stage:Series A, Seed
  • Geography: Finland, Sweden, United States

Investor stats

  • Total investments: 6
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Nuuka — Nuuka is a building SW scaleup from Finland. Nuuka specialises in diagnosing and optimising HVAC, energy systems, and indoor climate. The SaaS is optimal for large building portfolios, of new and old public and commercial buidlings, as it can be used with any BMS and HVAC system, IAQ sensor or energy meter. Nuuka improves indoor climate, energyefficiency, reduces operational cost and improves sustainability for real estate owners, developers, retail chains and whole cities. We use SW, AI and ML to transform and industry, and save the world one building at the time.
  • Oricane — Buy the domain name Oricane.com and launch your business with a premium domain and a high quality logo.
  • ResQ Club — ResQ Club is a Finnish company connecting sustainable restaurants, cafes, and grocery stores with consumers that appreciate eating affordable quality food. ResQ partners can drastically reduce their food waste with their proprietary location-based mobile and web service, as it enables consumers to find and rescue surplus food in their proximity.Every meal purchased via ResQ is one less meal thrown away, helping their urban communities to waste less and be more sustainable.They are on a mission to reduce food waste to zero at restaurants, cafes, and grocery stores. It's estimated that 10% of the already produced food in restaurants ends up in the trash instead of hungry mouths. On a global scale, this equals 11 million tons of food wasted every year.
Show all investments...

Unifund
VC Fund · 1 investments in Finland Biotechnology startups

Unifund Jyväskylä Ltd is to support the start-up of research-based businesses.

Show more...

Investment focus

  • Industry: Software, Collaboration, Management Consulting
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Humap — Howspace is an AI-powered online platform that brings digital collaboration and social learning to the forefront of your process & development initiatives.
  • PrecisionPhage — PrecisionPhage is a biotech business that specializes on bacteriophage technologies.
Show all investments...

Ananda Impact Ventures
VC Fund · Munich, Bayern, Germany · 1 investments in Finland Biotechnology startups

We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, United Kingdom, Finland

Investor stats

  • Total investments: 66
  • Lead/follow: no public data

Portfolio highlights

  • Elio — Putting leading scientific data into context, to enable others to respond to climate change’s dynamism and act on solutions with confidence.
  • Ocean Ledger — Precision analytics to design, implement & monitor coastal mitigation and adaptation.
  • NatureMetrics — NatureMetrics is the World-Leading provider of Biodiversity monitoring data, using eDNA surveys, metabarcoding & more. Book your demo today!
Show all investments...

The Forum Corporation
VC Fund · Boston, Massachusetts, United States · 1 investments in Finland Biotechnology startups

Fortum Oyj is a global learning and development firm specializing in strategy execution for companies in a broad array of industries.

Show more...

Investment focus

  • Industry: Biotechnology
  • Stage:Series A
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Infinited Fiber Company — Infinited Fiber Company is a Finnish biotech founded in 2016 to commercialize a breakthrough recycling technology that can turn cellulose-rich raw materials – like cotton-rich textile waste, used cardboard, or wheat or rice straw – into high-quality textile fibers with the look and feel of cotton. The patented technology has been validated byleading brands and is ready to be scaled. Infinited Fiber Company won the Europas 2020 Hottest Sustainability Tech Award, and was listed on the Global 50 to Watch by Cleantech Group in 2019. In 2016 Infinited Fiber Company was selected into WWF’s Climate Solver network. The company is headquartered in Espoo, Finland.
Show all investments...

Moomin Characters
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Moomin Official Site: discover Moominvalley and the magical characters created by Tove Jansson. Get the latest Moomin news and stories.

Show more...

Investment focus

  • Industry: Biotechnology, Environmental Engineering
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Origin by Ocean — We rid the oceans of harmful algae and turn it into everyday goods.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
XR Invest
VC Fund · 1 investments in Finland Biotechnology startups

XR Invest is an investment firm focused on medtech and digital health early-stage start-ups.

Show more...

Investment focus

  • Industry: Medical Device, Sensor, Medical
  • Stage:Series A, Series C
  • Geography: Finland, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 67% lead, 33% follow

Portfolio highlights

  • Augmedics — Augmedics is a provider of augmented reality (AR) surgical image guidance solutions. Augmedics seeks to improve healthcare by developing cutting-edge technologies that will revolutionize surgical treatment. The company’s first product, the xvision-spine (XVS) system, is an augmented-reality surgical navigation system designed to allow surgeons tosee and navigate inside a patient’s body during complex procedures.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

Visionplus
VC Fund · Helsinki, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

WE HELP YOU TO GROW FASTER!

Show more...

Investment focus

  • Industry: Software, Information Technology, Internet
  • Stage:Seed, Series A
  • Geography: Finland, United States, United Kingdom

Investor stats

  • Total investments: 74
  • Lead/follow: no public data

Portfolio highlights

  • Pebble — Pebble is a electric vehicle manufacturing startup.
  • Transfluent — Professional translations for all business needs. Fast. Easy.
  • BetterDoctor — Our provider network software solutions & services provide unmatched tools & insights for you. Discover how you can measure, manage, monitor & model.
Show all investments...

Oy Hammaren & Co Ab
VC Fund · Finland, Minnesota, United States · 1 investments in Finland Biotechnology startups

Oy Hammaren & Co Ab provides financial services and insurance activities.

Show more...

Investment focus

  • Industry: Health Care, Wellness, GreenTech
  • Stage:Angel, Series A
  • Geography: Finland

Investor stats

  • Total investments: 4
  • Lead/follow: no public data

Portfolio highlights

  • Naava — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
  • Heltti — We are Heltti! We help people and knowledge workplaces feel better.
  • NaturVention — Naava helps you to make safer and healthier indoor spaces - experience Naava green wall, a striking combination of nature and high-end technology.
Show all investments...

Lynx Capital
VC Fund · Shanghai, Shanghai, China · 1 investments in Finland Biotechnology startups

cross-border, healthcare, life science, investment, VC, China, US

Show more...

Investment focus

  • Industry: Therapeutics, Biotechnology, Pharmaceutical
  • Stage:Series A
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Bone Index Finland — Bindex® is – in addition to DXA devices – the only device that can be used for osteoporosis diagnostics with international guidelines (ISCD) and the Finnish Current Care Guidelines (04/2014).Bindex® is applied by measuring the cortical thickness of tibia. The results, combined with other patient data, are used to estimate the hip region’sbone mineral density. Bone mineral density values (g/cm2) are normally only received via the large DXA devices used in hospitals.Bindex®’s quickness and simplicity make its use possible in high volume risk group screenings. It makes the identification of an osteoporosis risk possible before the first bone fracture has even occurred. Thus, it both improves the patient’s quality of life and saves on public health care expenses.
  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
Show all investments...

Gaingels
VC Fund · New York, New York, United States · 1 investments in Finland Biotechnology startups

Gaingels is a venture investment syndicate in service of the LGBT+ community and its allies, investing in companies with LGBT+ founders and C-suite leaders at all stages of growth, as well as in more established companies resolved on building more inclusive teams, with a global portfolio of 130+ companies and $70M in deployed investment capital todate. The Gaingels network also actively supports its portfolio in identifying and recruiting diverse talent to their C-suite and board leadership teams and fosters a vibrant global community of industry leaders, investors, operators, and entrepreneurs who share a common goal for positive social change through business and successful investments.

Show more...

Investment focus

  • Industry: Software, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 629
  • Lead/follow: no public data

Portfolio highlights

  • Ashby — Ashby is a developer of recruitment software used for high-growth companies. It develops usable, enterprise-grade employment software that enables company leaders, recruiters, and hiring managers to run their hiring process significantly better. It was founded in 2018 and is based in San Francisco, California.
  • Paxton — Regulatory Intelligence, with the speed of Generative AI.
  • Viridian Space — Viridian Space develops a propulsion technology intended to use oxygen to stay in ultra-low earth orbit. The company was founded in 2021 and is based in Culver City, California.
Show all investments...

Novartis Venture Fund
VC Fund · Basel, Basel-Stadt, Switzerland · 1 investments in Finland Biotechnology startups

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Switzerland, United Kingdom

Investor stats

  • Total investments: 209
  • Round size: Series A $4.7M–$81M; Series B $11M–$105M; Series C $9M–$75M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2009

Portfolio highlights

  • Rhygaze — Rhygaze develops a novel gene therapy that targets cone cells to restore vision in patients suffering from diseases causing blindness.
  • Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
  • Amphista Therapeutics — We are purposefully designing the next generation of targeted protein degraders to transform the lives of patients with intractable diseases.
Show all investments...

Aqua Spark
VC Fund · Utrecht, Utrecht, The Netherlands · 1 investments in Finland Biotechnology startups

Aqua-Spark is an investment fund with a focus on sustainable aquaculture businesses around the world. The small-to-medium enterprises (SMEs) they invest in are working toward the production of safe, accessible aquatic life, such as fish, shellfish and plants, in ways that do not harm their oceans. Their investors value the fact that each investmentaims to create triple impact—specifically, each investment is chosen for its potential to generate significant financial returns while also activating positive environmental and social outcomes.Aqua-Spark believes that committing to a long-term vision is the way to realize effective and lasting impact results. When it comes to investments, they do not seek quick exits; instead, they look for entrepreneurs who strive to build and scale toward the future, who see their business as major economic opportunities that can also help solve looming environmental and food security challenges over the long-term. As an essential of each investee, Aqua-Spark seeks sustainability.

Show more...

Investment focus

  • Industry: Biotechnology, Aquaculture, Seafood
  • Stage:Series A, Seed
  • Geography: United States, Norway, Israel

Investor stats

  • Total investments: 40
  • Lead/follow: no public data

Portfolio highlights

  • Protix — Discover how Protix is revolutionizing the food system by converting organic waste into nutritious insect-based ingredients for a sustainable future.
  • XpertSea — XpertSea is a Canadian technology company that's transforming how the global aquaculture industry farms seafood to help feed the world. Combining smart aquaculture equipment with a farm management platform, our collaborative solution uncovers actionable insights driven by artificial intelligence. These insights enable farmers and industryexperts to optimize feed efficiency, reduce environmental waste, take preventive actions against diseases and use data to bring transparency and knowledge to the entire supply chain. With customers in over 50 countries, we’re using Canadian ingenuity to make aquaculture profitable and sustainable.
  • Proteon Pharmaceuticals — Proteon Pharmaceuticals serves livestock and aquaculture farms that aim for high-quality and sustainable protein production.
Show all investments...

Lundbeckfonden Ventures
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Finland Biotechnology startups

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Denmark, United Kingdom

Investor stats

  • Total investments: 65
  • Round size: Series A $10M–$50M; Series B $20M–$95M; Series C $16M–$53M
  • Lead/follow: 32% lead, 68% follow

Portfolio highlights

  • ENTEROME — We are a clinical stage biopharmaceutical company developing novel drugs to transform human health based on our unique ability to de-code molecular interactions in the gut microbiome.
  • Kvantify — Quantum computing will revolutionize many aspects of computing. We can help your business harness the full potential of Quantum Computing and High-Performance Computing today.
  • Notify Therapeutics — Notify Therapeutics develops therapies for the treatment of infertility. By targeting the early and hormone-independent phase of egg maturation, the company aims at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy. It utilizes drug-inducing factors that regulate the intracellular AKTpathway and target the early and hormone-independent phase of egg maturation for the treatment.
Show all investments...

Agronomics
VC Fund · Douglas, South Lanarkshire, United Kingdom · 1 investments in Finland Biotechnology startups

Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: United States, Finland, Germany

Investor stats

  • Total investments: 44
  • Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
  • Lead/follow: 48% lead, 52% follow

Portfolio highlights

  • BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
  • Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
  • Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Show all investments...

K5 Global
VC Fund · Los Angeles, California, United States · 1 investments in Finland Biotechnology startups

Backing category-defining companies from inception to IPO.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Brazil

Investor stats

  • Total investments: 174
  • Round size: Seed $100k–$10M; Pre-Seed $50k–$3.4M; Series A $75k–$50M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Balsa — Balsa Build is a next generation project management tool that helps you ship faster by providing better visibility and coordination across existing tools like Jira and Github in one central location.
  • Kled AI — Meet Nitrility, The World's First Intellectual Property Marketplace.
  • Chain — Chain is a pop-up restaurant that accepts deliveries and offers popular chain restaurant dishes.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Conor Venture Partners
VC Fund · Espoo, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Conor Venture Partners is a new breed technology venture capital fund and management company. Conor invests in early-stage companies originating from Nordic and Baltic countries. Investment areas include information and communications technology, embedded software, semiconductor technology, electronics, new materials and optics.

Show more...

Investment focus

  • Industry: Software, Analytics, Semiconductor
  • Stage:Series A, Series B, Seed
  • Geography: Finland, United States, Sweden

Investor stats

  • Total investments: 45
  • Round size: Seed $1.1M–$3.3M; Series A $3.9M–$8.8M; Series B $2.4M–$16M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $60M in 2010

Portfolio highlights

  • Neo4j — Connect data as it's stored with Neo4j. Perform powerful, complex queries at scale and speed with our graph data platform.
  • Blackwood Seven — Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.
  • Verto Analytics — Verto Analytics (Verto) operates a passive metering panel that provides researchers, advertisers, and publishers the data they need to keep up with the rapid and changing pace of consumer media consumption on every app, device, service, and platform. This ongoing, longitudinal panel captures a wide breadth of behaviors—all enriched to clients’behavioral analysis or custom survey studies. Our single-source, passive metering data sets provide the information needed to understand the full digital footprint of the U.S. population. Our Data Labs are located in the US, and in Helsinki, Finland. http://www.vertoanalytics.com.
Show all investments...

Capricorn Partners
VC Fund · Leuven, Vlaams-Brabant, Belgium · 1 investments in Finland Biotechnology startups

Capricorn Partners is a unique independent manager of venture capital, growth capital and quoted equity funds

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Belgium, United States, The Netherlands

Investor stats

  • Total investments: 112
  • Round size: Series A $3.3M–$18M; Series B $5.3M–$42M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Neotiv — Enabling cognitive health
  • Thryve — Thryve’s SDK brings everything you need to access fragmented wearable, medical devices, and health data silos with a single integration. We unify your users’ data from smartwatches, blood glucose meters, and many other sources that unlock a continuous stream of harmonized health information for your care. We support popular data sources like AppleHealth, Google Fit, Huawei Health, Samsung Health, and many more.
  • VOID Technologies — VOID Technologies is a groundbreaking materials science company spun out of Kimberly-Clark to commercialise the VO+ technology. Our business model is based on supplying VO+ additive masterbatches to film manufacturers.
Show all investments...

H&M Group Ventures
VC Fund · Stockholm, Stockholms Lan, Sweden · 1 investments in Finland Biotechnology startups

H&M Group Ventures is the venture capital arm of the H&M Group.

Show more...

Investment focus

  • Industry: E-Commerce, Fashion, Textiles
  • Stage:Series A, Series B
  • Geography: Sweden, United States, United Kingdom

Investor stats

  • Total investments: 55
  • Round size: Series A $1.9M–$50M; Series B $14M–$40M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Centra — Centra is part of creating the next generation of brands, with a direct-to-consumer and wholesale e-commerce software for global brands. Brands across Scandinavia and the world trust Centra to seamlessly connect people to products. We're a medium-sized company with offices in Stockholm, Sweden, Wroclaw, Poland and New York City, USA.
  • Colorifix — Colorifix is a biotechnology company that has pioneered the first entirely biological process to produce, deposit and fix pigments onto textiles. Using a synthetic biology approach, it offers a radically different solution to incumbent dyeing technologies that entirely cuts out the use of harsh chemistry and leads to huge reductions in waterconsumption. Colorifix’s investors include Cambridge Enterprise, H&M, Mills Fabrica, Primera Impact and Sagana, whose collective backing is funding its expansion. For more information, visit www.colorifix.com
  • Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.
Show all investments...

Keksintösäätiö
VC Fund · 1 investments in Finland Biotechnology startups

Keksintösäätiö

Show more...

Investment focus

  • Industry: Apps, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Finland

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • TILT Biotherapeutics — TILT Biotherapeutics is the leading company globally working in the area of enabling tumor T-cell therapy with oncolytic viruses. TILT is a preclinical stage company working in the field of cancer immunotherapy and will soon translate its unique approach into clinical trials. The company’s patented technology involves utilization of oncolyticviruses for enhancement of tumor T-cell therapy. Initial embodiments of the technology will be used to enhance tumor infiltrating lymphocyte (TIL), chimeric antigen receptor (CAR-T) and checkpoint inhibiting antibody therapy. The TILT approach has the potential to achieve similar results in CAR-T therapy of solid tumors as currently achieved for CD19+ hematological tumors.
Show all investments...

Thames Trust
VC Fund · London, England, United Kingdom · 1 investments in Finland Biotechnology startups

Thames Trust

Show more...

Investment focus

  • Industry: SaaS, FinTech, Finance
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, Finland

Investor stats

  • Total investments: 3
  • Lead/follow: 33% lead, 67% follow

Portfolio highlights

  • STEM — For makers, learners, and players. Creative computing projects, stories, and more.
  • Algorithmiq — Algorithmiq utilizes its expertise in quantum information, complex systems, and computational physics to develop algorithms to develop new and effective drugs, solve problems in life sciences, and discover new materials.
  • ABAKA Holdings — Fintilect delivers hyper-personalized digital banking solutions to financial institutions, empowering them to adapt, respond and prosper. Find out more.
Show all investments...

Metsola Ventures
VC Fund · Espoo, Southern Finland, Finland · 1 investments in Finland Biotechnology startups

Metsola Ventures

Show more...

Investment focus

  • Industry: Medical, mHealth, Health Care
  • Stage:Series A
  • Geography: Finland

Investor stats

  • Total investments: 2
  • Round size: Series A $2.2M–$4.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Kaiku Health — Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation.
  • Synoste Oy — Globus Medical develops, manufactures, and distributes musculoskeletal device solutions. Learn about the implants and products we manufacture.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 1 investments in Finland Biotechnology startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 57
  • Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 1 investments in Finland Biotechnology startups

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 76
  • Round size: Seed $1M–$9.8M; Series A $1M–$20M; Series B $7M–$45M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • FineHeart — Our mission is to address the unmet need of patients with sever heart failure
  • 480 Biomedical — 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown,Massachusetts.
  • HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
Show all investments...

Athensmed
VC Fund · 1 investments in Finland Biotechnology startups

Athensmed Oy

Show more...

Investment focus

  • Industry: Health Care, Medical, mHealth
  • Stage:Seed, Series A
  • Geography: Finland

Investor stats

  • Total investments: 4
  • Round size: Seed $1.1M–$1.3M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • VideoVisit — VideoVisit is a Nordic health technology company, developing digital solutions for home care and healthcare sectors. They make healthcare available to everyone, anywhere and anytime, and strive to provide solutions that help people live independently at home for as long as possible. They collaborate with healthcare specialists to ensure that oursolutions are available to everyone.
  • Finnadvance — Finnadvance is an Organ-On-Chip company developing high throughput biological barriers on chips to mimic human biology such as vascular, lung and the Blood-Brain-Barriers for small molecule, micro-nano-formulation permeability and toxicity testing with in-vivo like dynamic cell cultures.
  • Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
Show all investments...

Zhejiang Huahai Pharmaceutical
VC Fund · Linhai, Zhejiang, China · 1 investments in Finland Biotechnology startups

Zhejiang Huahai Pharmaceutical Co. Ltd. is a Phermaceutical Company.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Therapeutics
  • Stage:Series A
  • Geography: China, Finland

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • Aurealis Therapeutics — Multi-target cell and gene therapies for unmet medical needs. Developing therapies for chronic wounds, cancer and inflammatory diseases.
  • Yannuo Pharmaceutical — Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conductsresearch and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.
Show all investments...

Biotechnology VC funding in Finland at a glance

Stats across 122 deals from 108 investors.

108
investors
in Finland Biotechnology startups
122
deals
in Finland Biotechnology startups
$3.2M
median round
in Finland Biotechnology startups
47%
lead investors
lead at least one round
16%
Seed
most common funding stage

Access all 108 VC funds in Finland Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in Finland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 108 VC funds investing in Finland Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists